Document Detail


Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
MedLine Citation:
PMID:  21277406     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
In the United States, human papillomavirus (HPV) vaccination is recommended for 11 or 12 year old girls, with catch-up vaccination through age 26 years. Data are available for women over the age of 26 years on immunogenicity for both quadrivalent and bivalent HPV vaccines and on efficacy for the quadrivalent HPV vaccine. If HPV vaccines are licensed for use in women over 26 years of age (mid-adult women), recommendations for this age group will need to be considered. This review summarizes vaccine efficacy and immunogenicity data in mid-adult women, and addresses epidemiologic data related to key questions for consideration of vaccine recommendations for women over age 26 years.
Authors:
Linda Ahdieh Grant; Eileen F Dunne; Harrell Chesson; Lauri E Markowitz
Related Documents :
21353946 - A multiplex polymerase chain reaction method for rapid pneumococcal serotype determinat...
21557976 - Willingness of pregnant women to vaccinate themselves and their newborns with the hpv v...
21501306 - Effect of the pneumococcal conjugate vaccine on pneumococcal carriage in turkish children.
21457726 - Contact and communication with healthcare providers regarding influenza vaccination dur...
23633406 - Safety of zoster vaccine in elderly adults following documented herpes zoster.
12831526 - Rickettsia typhi infection in wild rodents from central spain.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-27
Journal Detail:
Title:  Vaccine     Volume:  -     ISSN:  1873-2518     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406899     Medline TA:  Vaccine     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Affiliation:
Division of STD Prevention, Centers for Disease Control and Prevention, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of...
Next Document:  Bacillus Calmette-Guérin vaccination using a microneedle patch.